Why the study?
Incomplete LAA occlusion after transseptal occluder implantation necessitates anticoagulation in persistent AF, leaving patients with contraindications to lifelong anticoagulation challenging to treat and in need of alternative options.
Answers are grounded in this paper and cite their sources.
Surgical LAA clip insertion may be a viable alternative for patients with incomplete LAA occlusion after transseptal device implantation who cannot tolerate lifelong anticoagulation.
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, requiring lifelong anticoagulation or interventional, transseptal left atrial appendage (LAA) occluder implantation to minimize stroke risk. Incomplete LAA closure post implantation is a frequent observation. Incomplete LAA occlusion after transseptal occluder implantation necessitates anticoagulation in cases of persistent AF to minimze risk of embolism and/or apoplexy. Patients with contraindications to lifelong anticoagulation therapy are challenging to treat and alternative options are needed. We present a case of a patient with persistent AF who underwent frustraneous LAA occluder implantation. The patient's anatomy necessitated surgical closure of the LAA, which was accomplished with an LAA clip 4 weeks after implantation. The patient was discharged in excellent clinical status 5 days after the surgery. No further complications were observed within the following year.
No takes yet. Share an insight, caveat, or question.
Çetinkaya et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: